Tag: Cannabis Retailers and Medical Cannabis Retailers
-
Harborside (HBOR.C) books 2020 revenues of $63 million – 130% of its market cap
Harborside’s full year 2020 gross revenues expanded 29% year-over-year to $63.4 million.
-
Harborside (HBOR.C) invests $5-million in Loudpack – a CA cultivator with a deep portfolio of branded products
Loudpack is a California cannabis company with “a broad cultivation, manufacturing, processing, and distribution footprint and a strong portfolio of brands”.
-
Harborside (HBOR.C) raises $20 million, narrows focus on California, projects 2021 cannabis revenues equal to its current market cap
The January 20, 2021 press release declared that HBOR is “expecting gross revenues in line with previously issued guidance of approximately $61 – 63 million, and positive EBITDA”.
-
Harborside (HBOR.C) buys another California dispensary
With HBOR’s track record of revenue-growth-per-location, the addition of FGW is likely to accelerate revenue growth.
-
Harborside (HBOR.C) reports good Q3, 2020 financial results
During Q3 2020, Harborside generated total gross revenues of approximately $19.6 million, representing a 21.2% sequential growth over Q2, 2020
-
Harborside (HBOR.C) upgrades California grow-op, launches clone sales, pushes rev. projections higher
The company’s in-house brand, Harborside Farms will begin sales of clones grown at its Salinas facility at all Harborside branded locations, including Desert Hot Springs.
-
Harborside (HBOR.C) adds to San Francisco dispensary portfolio
On October 19, 2020 Harborside (HBOR.C) announced that it has reached a definitive agreement to acquire 50.1% of FGW Haight – a California co. that has the “conditional-use approval” to operate a cannabis dispensary and related businesses in the iconic Haight Ashbury area of San Francisco, Calif.